期刊
NATURE REVIEWS CANCER
卷 15, 期 9, 页码 540-555出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3982
关键词
-
类别
资金
- Portuguese Foundation for Science and Technology (FCT)
- European Regional Development Fund (FEDER) through the Operational Programme for Competitiveness Factors (COMPETE)
- national funds through the FCT [PEst-C/SAU/LA0003/2013, PTDC/BBB-EBI/0786/2012, EXPL/BIM-MEC/0149/2012]
- FCT [SFRH/BPD/63094/2009]
- European Union Seventh Framework Programme GastricGlycoExplorer [316929]
- Fundação para a Ciência e a Tecnologia [EXPL/BIM-MEC/0149/2012, PTDC/BBB-EBI/0786/2012, PEst-C/SAU/LA0003/2013] Funding Source: FCT
Despite recent progress in understanding the cancer genome, there is still a relative delay in understanding the full aspects of the glycome and glycoproteome of cancer. Glycobiology has been instrumental in relevant discoveries in various biological and medical fields, and has contributed to the deciphering of several human diseases. Glycans are involved in fundamental molecular and cell biology processes occurring in cancer, such as cell signalling and communication, tumour cell dissociation and invasion, cell-matrix interactions, tumour angiogenesis, immune modulation and metastasis formation. The roles of glycans in cancer have been highlighted by the fact that alterations in glycosylation regulate the development and progression of cancer, serving as important biomarkers and providing a set of specific targets for therapeutic intervention. This Review discusses the role of glycans in fundamental mechanisms controlling cancer development and progression, and their applications in oncology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据